Cardinal Health, Inc.

Cardinal Health, Inc.

CAH

$221.27

Updated: 24/09/2026, 14:03:56

Market Cap
$51.82B
Sector
Healthcare
Industry
Medical - Distribution
Country
US
Stock valuation chart
One-year closing share-price history for CAH
Company Profile

Cardinal Health, Inc. operates as a global, integrated provider of healthcare services and products, with its reach spanning the United States, Canada, Europe, Asia, and other international markets. The company delivers bespoke support to a diverse clientele, including hospitals, healthcare networks, pharmacies, outpatient surgical centers, clinical labs, physician practices, and individuals receiving care at home. It is structured into two core divisions: Pharmaceutical and Medical. The Pharmaceutical division oversees the distribution of a wide array of products, encompassing branded, generic, and specialty pharmaceuticals, along with over-the-counter health and consumer goods. This segment additionally offers specialized services to pharmaceutical manufacturers and healthcare providers, particularly for specialty pharmaceutical products. Its operations extend to managing nuclear pharmacies and facilities that produce radiopharmaceuticals. It also performs repackaging of generic drugs and OTC items. Further offerings include medication therapy management and patient outcomes services for hospitals, other healthcare providers, and payers, in addition to providing pharmacy management solutions to hospitals. The Medical division focuses on producing, sourcing, and supplying Cardinal Health-branded medical, surgical, and laboratory products and devices. This extensive product range encompasses items such as examination and surgical gloves, needles, syringes, sharps disposal units, compression products, incontinence aids, nutritional delivery systems, wound care supplies, single-use drapes, gowns, and apparel, fluid suction and collection devices, urological products, operating room essentials, and electrodes. Beyond its proprietary brands, this segment also distributes various national brand medical, surgical, and laboratory products. It offers comprehensive supply chain management for hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare organizations, and manufactures and sells both sterile and non-sterile procedure kits. Established in 1979, the company maintains its headquarters in Dublin, Ohio.

USD
NYSE
CEO: Jason Hollar
Employees: 61,344
https://www.cardinalhealth.com
Asset Summaries
Latest generated summaries for CAH

No summaries found.

Detailed business
The latest official filing is available; structured extraction is pending.
CAH-10-k-fy2026.html2.8 MBtext/htmlENFiled 11/08/2026Period ended 30/06/2026

The original document can be viewed now. Detailed facts and exposure relationships will appear after the separate extraction job completes.

Full company information
Latest profile, trading, valuation, and identifier data stored for CAH.
Share price
$221.27
Market cap
$51.82B
Exchange
NYSE
Currency
USD
CEO
Jason Hollar
Employees
61,344
IPO date
04/08/1983
Beta
0.519
Last dividend
$0.00
Day range
$220.94 – $225.64
52-week range
$145.87 – $258.30
1-day performance
-0.35%
1-year performance
51.69%
Current drawdown (1Y)
-14.34%
CIK
0000721371
CUSIP
14149Y108
ISIN
US14149Y1082
Created
07/12/2025, 03:10:40
Last update
24/09/2026, 14:03:56

Track Cardinal Health, Inc. with an AI analyst

See which prediction-market events move CAH, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.

Latest Database News
News linked to CAH from your Railway `news_articles` table.

Is Cardinal Health (CAH) Stock Undervalued Right Now?

Zacks Investment Research • STOCK • 12/06/2026, 12:41:11

Here's Why Cardinal Health (CAH) is a Strong Value Stock

Zacks Investment Research • STOCK • 01/06/2026, 12:42:35

CAH vs. COR: Which Healthcare Distributor Stock Is the Better Buy?

Zacks Investment Research • STOCK • 27/05/2026, 14:11:13

Is Cardinal (CAH) a Buy as Wall Street Analysts Look Optimistic?

Zacks Investment Research • STOCK • 27/05/2026, 12:30:34

Can CAH's Surging Other Growth Businesses Become Its Next Profit Engine?

Zacks Investment Research • STOCK • 25/05/2026, 14:16:05

Cardinal Health (CAH) is a Top-Ranked Momentum Stock: Should You Buy?

Zacks Investment Research • STOCK • 25/05/2026, 12:51:14

Here's Why You Should Add Cardinal Health Stock to Your Portfolio Now

Zacks Investment Research • STOCK • 20/05/2026, 17:35:24

3 Reasons Why Growth Investors Shouldn't Overlook Cardinal (CAH)

Zacks Investment Research • STOCK • 20/05/2026, 15:45:14

Is CAH Becoming the Backbone of US Healthcare Infrastructure?

Zacks Investment Research • STOCK • 19/05/2026, 17:30:50

CAH Stock Down Nearly 9.4% YTD: Should You Buy, Hold or Sell?

Zacks Investment Research • STOCK • 14/05/2026, 16:10:41

Cardinal Health, Inc. (CAH) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Seeking Alpha • STOCK • 13/05/2026, 18:10:45

Can CAH Sustain Growth on Booming Pharmaceutical & Specialty Segment?

Zacks Investment Research • STOCK • 13/05/2026, 13:40:45